Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03850366
Title HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Henry Ford Health System
Indications

hematologic cancer

Therapies

Bortezomib + Cyclophosphamide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Henry Ford hospital Recruiting Detroit Michigan 48202 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field